Marco Contoli

About Marco Contoli

Marco Contoli, With an exceptional h-index of 45 and a recent h-index of 37 (since 2020), a distinguished researcher at Università degli Studi di Ferrara, specializes in the field of Respiratory Diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?

Long-term health care resource and cost savings with allergy immunotherapy: REACT study results

Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 2

Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients

Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study

N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses

Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration–European Lung Foundation …

Marco Contoli Information

University

Position

- Italy

Citations(all)

8216

Citations(since 2020)

3929

Cited By

5867

hIndex(all)

45

hIndex(since 2020)

37

i10Index(all)

98

i10Index(since 2020)

81

Email

University Profile Page

Google Scholar

Marco Contoli Skills & Research Interests

Respiratory Diseases

Top articles of Marco Contoli

Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?

Respiratory Medicine

2024/2/1

Roberto Rana
Roberto Rana

H-Index: 13

Marco Contoli
Marco Contoli

H-Index: 27

Long-term health care resource and cost savings with allergy immunotherapy: REACT study results

Journal of Allergy and Clinical Immunology: Global

2024/2/1

Marco Contoli
Marco Contoli

H-Index: 27

Nick Freemantle
Nick Freemantle

H-Index: 60

Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 2

Inflammation Research

2024/1

Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients

Molecular & Cellular Proteomics

2024/1/1

Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study

International Journal of Chronic Obstructive Pulmonary Disease

2024/12/31

N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses

Archivos de Bronconeumología

2024/3/18

Lorenzo Mancini
Lorenzo Mancini

H-Index: 2

Marco Contoli
Marco Contoli

H-Index: 27

Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration–European Lung Foundation …

ERJ Open Research

2023/7/1

Management of patients with chronic rhinosinusitis and nasal polyposis in Italy: expert opinion on the diagnostic-therapeutic approach (La gestione del paziente con …

Allergy

2021/3

Collaboration between explainable artificial intelligence and pulmonologists improves the accuracy of pulmonary function test interpretation

European Respiratory Journal

2023/5/1

Long-term, real-world effectiveness of allergy immunotherapy in younger children subgroup analysis of the react-study

The Lancet Regional Health–Europe

2022/2/1

NATURAL KILLER CELLS IN SARS-COV-2-VACCINATED SUBJECTS WITH INCREASED EFFECTOR CYTOTOXIC CD56DIM CELLS AND MEMORY-LIKE CD57+ NKG2C+ CD56DIM CELLS.

Frontiers in Bioscience-Landmark

2023/7/31

SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia

Journal of Inflammation

2023/11/20

From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital.

European Review for Medical & Pharmacological Sciences

2023/11/15

Update on virus-induced asthma exacerbations

2023/10/3

Serum Ige levels and blood eosinophils as potential Th2 inflammation biomarkers and target to address Chronic Cough: a retrospective analysis

2023/9/9

Marco Contoli
Marco Contoli

H-Index: 27

High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy …

Frontiers in Pediatrics

2023/3/28

Nick Freemantle
Nick Freemantle

H-Index: 60

Marco Contoli
Marco Contoli

H-Index: 27

See List of Professors in Marco Contoli University(Università degli Studi di Ferrara)